EUVIMEDEUVIMED entdecken
Kohortenstudie

Bidirectional association between type 2 diabetes and irritable bowel syndrome: A large‐scale prospective cohort study

Yesheng Zhou, Si Liu, Qian Zhang, Shutian Zhang, Shanshan Wu iD, Shengtao Zhu

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15852 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Yesheng Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical…. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To examine the bidirectional association between type 2 diabetes (T2D) and irritable bowel syndrome (IBS) in a large prospective population cohort.

Methods

Participants free of IBS at baseline in the UK Biobank were included in the analysis of T2D and incident IBS (cohort 1), with 11 140 T2D patients and 413 979 non‐T2D patients. Similarly, those free of T2D at baseline were included in the analysis of IBS and incident T2D (cohort 2), with 21 944 IBS patients and 413 979 non‐IBS patients. Diagnoses of T2D and IBS were based on International Classification of Disease‐10 codes. The Cox proportional hazards model was used to estimate adjusted hazard ratios (HRs).

Results

In cohort 1, 8984 IBS cases were identified during a median 14.5‐year follow‐up. Compared with non‐T2D, T2D patients had a 39.0% increased risk of incident IBS (HR = 1.39, 95% confidence interval [CI]: 1.23‐1.56, P < .001), with a higher IBS risk in those with higher fasting blood glucose levels (HR = 1.43, 95% CI: 1.19‐1.72, P < .001) or longer T2D duration (HR = 1.47, 95% CI: 1.23‐1.74, P < .001). In cohort 2, 29 563 incident T2D cases were identified. IBS patients had an 18.0% higher risk of developing T2D versus non‐IBS patients (HR = 1.18, 95% CI: 1.12‐1.24, P < .001). A similar excess T2D risk was observed in IBS patients with a duration of either less than 10 years, or of 10 years or longer. Further sensitivity analysis and subgroup analysis indicated consistent findings.

Conclusions

T2D and IBS exhibit a bidirectional association, with an increased risk of co‐morbidity. Awareness of this association may improve the prevention and management of both diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeDiabetes Mellitus, Type 2HumansFemaleMaleMiddle AgedProspective StudiesAdultUnited KingdomIncidenceAgedRisk FactorsBlood GlucoseProportional Hazards ModelsCohort StudiesFollow-Up Studies

Stichwörter der Autor:innen

cohort studiesdiabetesirritable bowel syndrome

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Diseases, Beijing, China.

ORCID-Profile: Shanshan Wu

Förderung

  • National Key Research and Development Program of China
  • Beijing Nova Program

Zitieren

APA

Zhou, Y., Liu, S., Zhang, Q., Zhang, S., Wu, S., & Zhu, S. (2024). Bidirectional association between type 2 diabetes and irritable bowel syndrome: A large‐scale prospective cohort study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15852

Vancouver

Zhou Y, Liu S, Zhang Q, Zhang S, Wu S, Zhu S. Bidirectional association between type 2 diabetes and irritable bowel syndrome: A large‐scale prospective cohort study. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15852

BibTeX
@article{Zhou2024,
  author = {Zhou, Yesheng and Liu, Si and Zhang, Qian and Zhang, Shutian and Wu, Shanshan and Zhu, Shengtao},
  title = {Bidirectional association between type 2 diabetes and irritable bowel syndrome: A large‐scale prospective cohort study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15852}
}
Kostenlos starten →